Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01526850Phase 3Unknown
A Phase 3 trial of mesenchymal stem cells in chronic graft-versus-host disease (cGVHD), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01526850.